Malaria Vaccine 'could be widespread by 2015'

No Image

The world's first malaria vaccine could be in widespread use within two years following "significant" results from an ongoing clinical trial.

Researchers reported at a malaria conference in Durban, South Africa, that the jab continues to protect a substantial proportion of babies and young children 18 months after vaccination. The mosquito-borne disease kills around 660,000 people every year, most of them children in Sub-Saharan Africa.

British pharmaceutical firm GlaxoSmithKline (GSK), which makes the vaccine, said it would apply for a licence from the European Medicines Agency next year.

Editor's Comment
Justice delayed is trust denied

Batswana who marched peacefully for 'Justice for Tshepi' demanded answers. They have now received a detailed account of police investigation and a promise that the file is with the Directorate of Public Prosecutions (DPP). The real test is whether the state now keeps its word without further prodding. In his address, the minister asked the nation to trust the process. He spoke of rigour, not neglect, and pointed to 10 months of...

Have a Story? Send Us a tip
arrow up